386 related articles for article (PubMed ID: 18579209)
21. Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy.
Kiss S; Ahmed M; Letko E; Foster CS
Ophthalmology; 2005 Jun; 112(6):1066-71. PubMed ID: 15936442
[TBL] [Abstract][Full Text] [Related]
22. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease.
Larkin G; Lightman S
Ophthalmology; 1999 Feb; 106(2):370-4. PubMed ID: 9951492
[TBL] [Abstract][Full Text] [Related]
23. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.
Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Deuter C
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1235-43. PubMed ID: 21720813
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression.
Becker MD; Wertheim MS; Smith JR; Rosenbaum JT
Ocul Immunol Inflamm; 2005; 13(4):289-93. PubMed ID: 16159719
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.
Saw VP; Dart JK; Rauz S; Ramsay A; Bunce C; Xing W; Maddison PG; Phillips M
Ophthalmology; 2008 Feb; 115(2):253-261.e1. PubMed ID: 17655931
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies.
Shen E; Rathinam SR; Babu M; Kanakath A; Thundikandy R; Lee SM; Browne EN; Porco TC; Acharya NR
Am J Ophthalmol; 2016 Aug; 168():279-286. PubMed ID: 27296490
[TBL] [Abstract][Full Text] [Related]
27. [Clinical observation of 85 patients with Behçet's uveitis treated with immunosuppressive agents combined with steroids].
Zhao M; Wang H; Jiao X; Wei WB
Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):202-6. PubMed ID: 23866699
[TBL] [Abstract][Full Text] [Related]
28. Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis.
Dodd KC; Ahmed R; Ambrose P; Holt JK; Jacob S; Leite MI; Miller JA; San PP; Spillane J; Viegas S; Sussman J
Neuromuscul Disord; 2024 May; 38():51-57. PubMed ID: 38626662
[TBL] [Abstract][Full Text] [Related]
29. Cyclophosphamide for ocular inflammatory diseases.
Pujari SS; Kempen JH; Newcomb CW; Gangaputra S; Daniel E; Suhler EB; Thorne JE; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Foster CS
Ophthalmology; 2010 Feb; 117(2):356-65. PubMed ID: 19969366
[TBL] [Abstract][Full Text] [Related]
30. [Indication and effect of immunosuppression in patients with scleritis].
Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP
Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507
[TBL] [Abstract][Full Text] [Related]
31. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.
Bhat P; Cervantes-Castañeda RA; Doctor PP; Anzaar F; Foster CS
Ocul Immunol Inflamm; 2009; 17(3):185-90. PubMed ID: 19585361
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis.
Kaplan-Messas A; Barkana Y; Avni I; Neumann R
Ocul Immunol Inflamm; 2003 Jun; 11(2):131-9. PubMed ID: 14533032
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of uveitis with immunosuppressives: antimetabolites and alkylating agents].
Caspers-Velu LE
Bull Soc Belge Ophtalmol; 2001; (279):49-59. PubMed ID: 11344715
[TBL] [Abstract][Full Text] [Related]
34. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
Greiner K; Varikkara M; Santiago C; Forrester JV
Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
[TBL] [Abstract][Full Text] [Related]
35. Enteric-coated mycophenolate sodium as a corticosteroid-sparing agent for the treatment of autoimmune scleritis.
Hwang YS; Chen HC; Chen KJ; Lai CC; Yeung L; Yang KJ; Lin KK; Hsiao CH
Cornea; 2011 Mar; 30(3):260-4. PubMed ID: 21099416
[TBL] [Abstract][Full Text] [Related]
36. Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders.
Baltatzis S; Tufail F; Yu EN; Vredeveld CM; Foster CS
Ophthalmology; 2003 May; 110(5):1061-5. PubMed ID: 12750115
[TBL] [Abstract][Full Text] [Related]
37. Mycophenolate mofetil in the treatment of uveitis in children.
Doycheva D; Deuter C; Stuebiger N; Biester S; Zierhut M
Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
[TBL] [Abstract][Full Text] [Related]
38. Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis.
Hogan AC; McAvoy CE; Dick AD; Lee RW
Ophthalmology; 2007 May; 114(5):1000-6. PubMed ID: 17467532
[TBL] [Abstract][Full Text] [Related]
39. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
40. Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis.
Kolomeyer AM; Ragam A; Shah K; Jachens AW; Tu Y; Chu DS
Ocul Immunol Inflamm; 2012 Apr; 20(2):113-8. PubMed ID: 22409564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]